MedPath

Peninsula Energy Ltd

Ownership
-
Employees
4.2K
Market Cap
-
Website
Introduction

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System

Completed
Conditions
Intracranial Aneurysms
Interventions
Device: PC 400 coils
First Posted Date
2012-12-21
Last Posted Date
2018-05-17
Lead Sponsor
Penumbra Inc.
Target Recruit Count
100
Registration Number
NCT01754051
Locations
🇫🇷

CHU Pellegrin, Bordeaux, France

Safety and Performance of the Penumbra Liberty Stent in the Treatment of Wide-Neck, Saccular, Intracranial Aneurysms

Phase 2
Withdrawn
Conditions
Wide Neck Intracranial Aneurysms
Interventions
Device: Liberty Stent
First Posted Date
2012-12-20
Last Posted Date
2019-04-12
Lead Sponsor
Penumbra Inc.
Registration Number
NCT01753388
Locations
🇩🇪

Asklepios Klinik Altona, Hamburg, Germany

🇩🇪

Universitätsklinikum des Saarlandes, Homburg/Saar, Germany

🇩🇪

Universitätsklinikum Magdeburg A. ö. R., Magdeburg, Germany

and more 1 locations

The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms

Not Applicable
Completed
Conditions
Wide-neck, Saccular Intracranial Aneurysms
Interventions
Device: Stent assisted coiling with the Liberty Stent
First Posted Date
2012-07-10
Last Posted Date
2018-08-23
Lead Sponsor
Penumbra Inc.
Target Recruit Count
120
Registration Number
NCT01636453
Locations
🇺🇸

Stony Brook University Medical Center, Stony Brook, New York, United States

🇺🇸

Swedish Medical Center, Denver, Colorado, United States

🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

Not Applicable
Completed
Conditions
Acute Ischemic Stroke From Large Vessel Occlusion
Interventions
Device: Penumbra System with Separator 3D
Device: Penumbra System alone
First Posted Date
2012-04-25
Last Posted Date
2018-09-13
Lead Sponsor
Penumbra Inc.
Target Recruit Count
198
Registration Number
NCT01584609
Locations
🇺🇸

Hoag Hospital, Newport Beach, California, United States

🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

🇺🇸

Stony Brook University Hospital, Stony Brook, New York, United States

and more 5 locations

Study of the Penumbra Coil 400 System to Treat Aneurysm

Not Applicable
Completed
Conditions
Peripheral Aneurysms
Intracranial Aneurysms
Interventions
Device: PC 400 coils (Penumbra )
First Posted Date
2011-11-06
Last Posted Date
2020-07-07
Lead Sponsor
Penumbra Inc.
Target Recruit Count
517
Registration Number
NCT01465841
Locations
🇺🇸

State University of New York Upstate Medical Center, Syracuse, New York, United States

🇺🇸

Hoag Hospital, Newport Beach, California, United States

🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

and more 3 locations

Assess the Penumbra System in the Treatment of Acute Stroke

Phase 4
Completed
Conditions
Ischemic Stroke
Interventions
Drug: intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
Device: Penumbra System
First Posted Date
2011-09-07
Last Posted Date
2020-09-22
Lead Sponsor
Penumbra Inc.
Target Recruit Count
108
Registration Number
NCT01429350
Locations
🇺🇸

Endovascular Surgical Neuroradiology, Swedish Medical Center, Denver, Colorado, United States

🇺🇸

Neurosurgery, Rush University Medical Center, Chicago, Illinois, United States

🇺🇸

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 1 locations

A Study of Survival and Outcome After Stroke

Completed
Conditions
Ischemic Stroke
First Posted Date
2010-09-02
Last Posted Date
2018-04-12
Lead Sponsor
Penumbra Inc.
Target Recruit Count
142
Registration Number
NCT01193569
Locations
🇬🇧

Acute Vascular Imaging Centre, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom

A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial

Completed
Conditions
Stroke
Interventions
Other: Current standard of care for acute ischemic stroke other than IV rtPA or other IA therapies
First Posted Date
2010-03-25
Last Posted Date
2019-04-12
Lead Sponsor
Penumbra Inc.
Target Recruit Count
150
Registration Number
NCT01092819
Locations
🇺🇸

Texas Stroke Institute, Plano, Texas, United States

🇨🇳

Queen Mary Hospital, Hong Kong, Hong Kong, China

🇨🇳

The Prince of Wales Hospital, Shatin, Hong Kong, China

Imaging Guided Patient Selection for Interventional Revascularization Therapy

Not Applicable
Completed
Conditions
Acute Ischemic Stroke
Interventions
Device: Penumbra System
First Posted Date
2009-08-24
Last Posted Date
2021-11-23
Lead Sponsor
Penumbra Inc.
Target Recruit Count
146
Registration Number
NCT00963989
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Penumbra Imaging Collaborative Study (PICS)

Completed
Conditions
Stroke
First Posted Date
2008-11-05
Last Posted Date
2018-04-12
Lead Sponsor
Penumbra Inc.
Target Recruit Count
289
Registration Number
NCT00785161
Locations
🇺🇸

Swedish Medical Center, Englewood, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath